Respiratory tract secretions in the dying patient: a comparison between glycopyrronium and hyoscine hydrobromide

Journal of Palliative Medicine
Heino HugelMaureen Gambles

Abstract

The evidence for the management of respiratory tract secretions (RTS) in dying patients with antimuscarinic drugs remains inconclusive. This study investigated the effectiveness of glycopyrronium versus hyoscine hydrobromide in controlling RTS using the Liverpool Care of the Dying Pathway (LCP) in 72 patients matched for age, diagnosis, and gender who died on a 30-bed specialist palliative care unit. All patients in the glycoypyrronium group had some response to glycopyrronium, whereas 22% of patients in the hyoscine group had no response to hyoscine hydrobromide. There was a significant difference in overall response between the two groups (p < 0.01). Twenty-eight percent of patients in the glycopyrronium and 42% of patients in the hyoscine group died with RTS present. There was no statistically significant difference in the levels of agitation following administration of either drug. This study provides further evidence that the LCP can be a useful tool in the evaluation of new drugs for symptom control in dying patients and suggests that glycopyrronium may be at least as effective in controlling RTS in dying patients as hyoscine hydrobromide.

References

Jul 1, 1979·British Journal of Anaesthesia·R K Mirakhur
Apr 1, 1995·Journal of Pain and Symptom Management·J E EllershawC M Saunders
Oct 1, 1996·Journal of Pain and Symptom Management·M I Bennett
Jun 20, 2000·Palliative Medicine·A HughesA King
Oct 17, 2002·Palliative Medicine·Mike BennettUNKNOWN Association for Palliative Medicine's Science Committee
Dec 31, 2002·Journal of Pain and Symptom Management·John E EllershawJennifer C Smith
Jul 26, 2003·BMJ : British Medical Journal·Elizabeth Rees, Janet Hardy
Oct 7, 2003·Journal of Pain and Symptom Management·Robin Martin Kåss, John Ellershaw

❮ Previous
Next ❯

Citations

Sep 8, 2012·Der Schmerz·T PastranaF Elsner
Apr 13, 2013·Drugs & Aging·Timothy E AlbertsonAndrew L Chan
Jul 4, 2012·Journal of Palliative Medicine·Takuya Shinjo, Masakuni Okada
Nov 21, 2013·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Sebastiano Mercadamte
Jun 25, 2013·Journal of Pain and Symptom Management·Martine E LokkerAgnes van der Heide
Jul 17, 2012·Journal of Pain and Symptom Management·Mark HeislerRichard Gerkin
Mar 31, 2012·Journal of Pain and Symptom Management·Marlene Z CohenEduardo Bruera
Mar 15, 2011·Journal of Pain and Symptom Management·Jane L PhillipsPatricia M Davidson
Dec 7, 2010·Journal of Pain and Symptom Management·Sebastiano MercadantePatrizia Ferrera
Apr 14, 2009·Journal of Pain and Symptom Management·Hans WildiersUNKNOWN Flemish Federation of Palliative Care
May 14, 2011·Scandinavian Journal of Caring Sciences·Simen A SteindalAnners Lerdal
Apr 13, 2011·Nursing in Critical Care·Nikolaos Efstathiou, Collette Clifford
Sep 29, 2007·Palliative Medicine·John Ellershaw
Sep 12, 2012·The American Journal of Hospice & Palliative Care·Eric Prommer
Aug 8, 2008·Current Opinion in Supportive and Palliative Care·María Laura Daud
Feb 24, 2009·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Polly E KintzelElizabeth A Clements
Feb 7, 2008·The Cochrane Database of Systematic Reviews·B Wee, R Hillier
Aug 11, 2015·Current Opinion in Supportive and Palliative Care·Finella CraigMyra Bluebond-Langner

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.